Replies to post #44479 on PharmaCyte Biotech Inc (PMCB)

[Alydyr]

They'll need a reverse split here in order to keep baiting the uneducated PMCB investor.

At .05/share a 1 for 20 would spike it to $1/share. So, I'll predict a 1 for 40 reverse split to keep it above $1 for awhile.

One thing for sure, PMCB will continue to collapse lower for quite some time.

PMCB

:(

[$Pistol Pete$]

$PMCB PHARMACYTE BIOTECH INCORPORATED (OTCMKTS:PMCB) Shorts Decreased by 66.54% After Short Covering

The stock of PHARMACYTE BIOTECH INCORPORATED (OTCMKTS:PMCB) registered a decrease of 66.54% in short interest. PMCB’s total short interest was 100,200 shares in December as published by FINRA. Its down 66.54% from 299,500 shares, reported previously. With 1.28M shares average volume, it will take short sellers 0 days to cover their PMCB’s short positions. The stock increased 1.39% or $0.001 on December 15, hitting $0.073. About 1.45 million shares traded hands. Pharmacyte Biotech Inc (OTCMKTS:PMCB) has declined 56.25% since May 13, 2015 and is downtrending. It has underperformed by 53.63% the S&P500.

Pharmacyte biotech, Inc., formerly Nuvilex, Inc. is a clinical-stage biotechnology company. The company has a market cap of $54.81 million. The Firm focuses on developing and preparing to commercialize treatments for cancer and diabetes based upon a cellulose live cell encapsulation technology known as Cell-in-a-Box. It currently has negative earnings. The Firm uses this technology as a platform upon which treatments for several types of cancer, including advanced, inoperable pancreatic cancer, and diabetes are developed.

Pharmacyte Biotech Inc - Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.


http://www.articlebasis.com/short-interest/pharmacyte-biotech-incorporated-otcmktspmcb-shorts-decreased-by-66-54-after-short-covering-32095.html

[$Pistol Pete$]

Kind a weird to point out all of the wrong and negatives information about PMCB so the stock can go down to buy it and then flip it to make some profit. What if the stock go lower and losing your money? I don't get it though. Maybe this is the way MM wants to do it? I see they hire bunch of people to do this job to scare investors away and sell it for a loss and then pump it up so investors buy it back at a higher price. Please help me out here. I see so much potential and cGMP facility status is on the way. Clinical Trials will start soon I don't think Longs will fall into this strap though....any thought?